These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 24933058)

  • 1. Paving a new road for generating evidence-based care in sepsis*.
    Annane D
    Crit Care Med; 2014 Jul; 42(7):1743-4. PubMed ID: 24933058
    [No Abstract]   [Full Text] [Related]  

  • 2. The authors reply.
    Opal SM; Dellinger RP; Vincent JL; Masur H; Angus DC
    Crit Care Med; 2014 Dec; 42(12):e798-9. PubMed ID: 25402303
    [No Abstract]   [Full Text] [Related]  

  • 3. Addressing the global burden of sepsis: importance of a systems-based approach.
    Dobson GP
    Crit Care Med; 2014 Dec; 42(12):e797-8. PubMed ID: 25402302
    [No Abstract]   [Full Text] [Related]  

  • 4. The next generation of sepsis clinical trial designs: what is next after the demise of recombinant human activated protein C?*.
    Opal SM; Dellinger RP; Vincent JL; Masur H; Angus DC
    Crit Care Med; 2014 Jul; 42(7):1714-21. PubMed ID: 24717456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Activated protein C and treatment of sepsis].
    Høibraaten E; Vangerow B
    Tidsskr Nor Laegeforen; 2004 May; 124(10):1422; author reply 1422-3. PubMed ID: 15195189
    [No Abstract]   [Full Text] [Related]  

  • 6. [New therapy for systemic infection and sepsis].
    Kasper SM
    Dtsch Med Wochenschr; 2002 Aug; 127(34-35):1736. PubMed ID: 12357970
    [No Abstract]   [Full Text] [Related]  

  • 7. New and emerging therapies for sepsis.
    Healy DP
    Ann Pharmacother; 2002 Apr; 36(4):648-54. PubMed ID: 11918516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sepsis therapy -- how effective are the therapy strategies?].
    Brunkhorst F; Reinhart K
    Chirurg; 2008 Sep; 79(9):877-8. PubMed ID: 18942197
    [No Abstract]   [Full Text] [Related]  

  • 9. We've made progress in the treatment of sepsis, so do we still need sepsis trials?
    Vincent JL
    Minerva Anestesiol; 2013 Jan; 79(1):1-2. PubMed ID: 23299044
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical impact of novel anticoagulation strategies in sepsis.
    Opal SM
    Curr Opin Crit Care; 2001 Oct; 7(5):347-53. PubMed ID: 11805532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant human-activated protein C (rhAPC) in childhood sepsis.
    Frassica JJ; Vinagre YM; Maas B
    J Intensive Care Med; 2004; 19(1):56-7. PubMed ID: 15035756
    [No Abstract]   [Full Text] [Related]  

  • 12. [Recombinant activated protein C: from evidence to clinical practice. Clinical practice guidelines for the use of activated proteins C in the treatment of severe sepsis].
    Heslet L; Nielsen JD; Schierbeck J; Andersen JS
    Ugeskr Laeger; 2004 Mar; 166(11):997-1002. PubMed ID: 15049234
    [No Abstract]   [Full Text] [Related]  

  • 13. FDA approves first biologic treatment for sepsis.
    Dent Today; 2002 Mar; 21(3):28, 30. PubMed ID: 11915215
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of severe sepsis and multiple organ failure with activated protein C].
    Strøm JJ
    Ugeskr Laeger; 2004 Mar; 166(11):995. PubMed ID: 15049233
    [No Abstract]   [Full Text] [Related]  

  • 15. Breakthrough found in treatment of severe sepsis.
    Clin Resour Manag; 2001 Jul; 2(7):107-9. PubMed ID: 11482248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Why are we still mesmerized by the old fashioned Medicine Man?
    Silvestri L; Rommes JH; Petros AJ; De La Cal MA; Taylor N; Van Saene HK
    Minerva Anestesiol; 2012 Dec; 78(12):1415. PubMed ID: 22672931
    [No Abstract]   [Full Text] [Related]  

  • 17. Recombinant human activated protein C in sepsis: inconsistent trial results, an unclear mechanism of action, and safety concerns resulted in labeling restrictions and the need for phase IV trials.
    Eichacker PQ; Natanson C
    Crit Care Med; 2003 Jan; 31(1 Suppl):S94-6. PubMed ID: 12544982
    [No Abstract]   [Full Text] [Related]  

  • 18. Activated protein C for sepsis.
    Toussaint S; Gerlach H
    N Engl J Med; 2009 Dec; 361(27):2646-52. PubMed ID: 20042756
    [No Abstract]   [Full Text] [Related]  

  • 19. Benefit-risk assessment of drotrecogin alfa (activated) in the treatment of sepsis.
    De Backer D
    Drug Saf; 2007; 30(11):995-1010. PubMed ID: 17973539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant human activated protein C.
    Hughes M
    Int J Antimicrob Agents; 2006 Aug; 28(2):90-4. PubMed ID: 16837170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.